Pharmacogenomics and Pharmacoproteomics

Pharmacogenomics & Pharmacoproteomics is the study of the role of genetics in drug response and provided DNA for genomes. It deals with the influence of acquired and inherited genetic variation on drug response in patients by Protein aggregation and stability in biopharmaceuticals, New discoveries in genomic targets, Various drug responses due to genetic polymorphisms, Drug dosage formulations, Drug safety and its efficacy and Membrane transport proteins. There are almost 3000 people from 60-65 universities in USA working for Proteomics. The NIH Pharmacogenomics Research Network (PGRN) is a network of scientists funding to PharmGKB since 2000.

  • Protein aggregation and stability in biopharmaceuticals
  • New discoveries in genomic targets
  • Various drug responses due to genetic polymorphisms
  • Drug dosage formulations
  • Drug safety and its efficacy
  • Membrane transport proteins

Related Conference of Pharmacogenomics and Pharmacoproteomics

June 13-14, 2024

30th Asia Pacific Biotechnology Congress

Dubai, UAE
July 11-12, 2024

6th International Conference on Biochemistry

Paris, France
September 25-26, 2024

20th World Congress on Structural Biology

Paris, France
October 03-04, 2024

15th International Conference on Biofuels and Bioenergy

Singapore City, Singapore
December 12-13, 2024

15th World Congress on Cell & Tissue Science

Rome, Italy

Pharmacogenomics and Pharmacoproteomics Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in